FACULTY & STUDENT SCHOLARSHIP
Ashley Rittenhouse (PharmD ’23) and J. Roberts and Marcia Fosberg Distinguished Regents Professor of Pharmacotherapy and Director of the Drug Information Center Danial Baker published, “Drug evaluation – vutrisiran (Amvuttra),” in Wolters Kluwer Health’s The Formulary Monograph Service (FMS) in October 2022. Wolters Kluwer Health is a drug and health information publisher, the FMS is a resource used in the formulary decision making process for hospitals and managed care systems on recently released and investigational drugs.
Danial Baker published, “Drug evaluation – Smallpox and monkeypox vaccine, live, non-replicating (Jynneos),” in the FMS in June October 2022.
Danial Baker published, “Drug evaluation – mirikizumab: preliminary evaluation,” in the FMS in October 2022.
Pharmacotherapy Clinical Professor and Director of Quality Assurance Improvement & Accreditation Preparation Terri Levien and Danial Baker published, “Drug evaluation – tecovirimat (TPOXX),” in the FMS in October 2022.
Drug Information Center Academic Resident Brittney Kessel and Danial Baker published, “Drug evaluation – rezafungin: preliminary evaluation,” in the FMS in October 2022.
Danial Baker published, “Drug utilization evaluation – tezepelumab (Tezspire),” in the FMS in October 2022.
United States Transuranium and Uranium Registries (USTUR) Director and Professor Sergei Tolmachev and two co-authors published, “ICP-MS analysis of actinides in brain tissue of an occupationally exposed individual,” in Journal of Radioanalytical and Nuclear Chemistry.
Pharmacotherapy Vice Chair & Allen I. White Distinguished Professor Joshua J. Neumiller published, “Nonsteroidal mineralocorticoid receptor antagonist in type 2 diabetes-associated chronic kidney disease,” in Clinical Care Options Endocrinology in July 2022.
Joshua J. Neumiller published, “Evidence for use of finerenone in T2D-associated CKD,” in Clinical Care Options Endocrinology in August 2022.
John White and one other presented, “GLP-1 receptor agonists: metabolic effects and their role in managing T2DM,” at the Tennessee Academy of Physician Assistants (TAPA) August 12, 2022, in Nashville, Tennessee.
Joshua J. Neumiller and one other presented, “Chronic kidney disease (CKD) in type 2 diabetes (T2D): an update for the DCES,” at the 2022 Annual Meeting of the Association for Diabetes Care and Education Specialists (ADCES) August 12, 2022, in Baltimore, Maryland.
Joshua J. Neumiller and two others presented, “Peripheral neuropathy: an update for the diabetes care & education specialist,” at the 2022 Annual Meeting of the ADCES.
The Denton lab finalized a material transfer agreement with Genentech to begin an Academic-Industry collaboration. Genentech will be providing pre-clinical in vitro and in vivo analyses on novel compounds recently developed in the Denton lab.
Josh Neumiller served as a Special Issue Editor for the journal Kidney and Dialysis on the topic of Diabetic Kidney Disease.